BOSTON SCIENTIFIC CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
BOSTON SCIENTIFIC CORPORATION (BSX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value of $780.00 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue · last filed 2026-02-17
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $780.00M.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $924.00M.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $458.00M.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $296.00M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value |
|---|---|
| 2025-12-31 | $780.00M 10-K · filed 2026-02-17 |
| 2024-12-31 | $924.00M 10-K · filed 2025-02-18 |
| 2023-12-31 | $458.00M 10-K · filed 2024-02-20 |
| 2022-12-31 | $296.00M 10-K · filed 2023-02-23 |
| 2021-12-31 | $295.00M 10-K · filed 2022-02-23 |
| 2020-12-31 | $312.00M 10-K · filed 2021-02-23 |
| 2019-12-31 | $590.00M 10-K · filed 2020-02-25 |
| 2018-12-31 | $495.00M 10-K · filed 2019-02-19 |
| 2017-12-31 | $302.00M 10-K · filed 2018-02-20 |
| 2016-12-31 | $277.00M 10-K · filed 2017-02-23 |
| 2015-12-31 | $238.00M 10-K · filed 2016-02-24 |
| 2014-12-31 | $144.00M 10-K · filed 2015-02-25 |
| 2013-12-31 | $135.00M 10-K · filed 2014-02-26 |
| 2012-12-31 | $0.00 8-K · filed 2013-05-29 |
| 2011-12-31 | $0.00 10-K · filed 2012-02-17 |
| 2010-12-31 | $3.00M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |